The valuations are coming near the industry valuations. My main motive for being interested in the company was the lower valuations compared the peers. Now I am seeing every other finfluencer covering the company on YouTube and linkedin posts for how it is the highest growing hospital. But since EV/EBITDA and PE is coming near the industry valuations, I doubt whether it makes sense to invest at these levels or not. The reason for worry is because of the “Issuer not cooperating” Rating by CRISIL, struggling free cashflows, and some issues going on within the management(as mentioned by someone above in the thread). Would like the views of others on these issues.
Disc. Holding a tracking position. No reco to buy/sell
| Subscribe To Our Free Newsletter |
